Prostate shapes on pre-treatment MRI between prostate cancer patients who do and do not undergo biochemical recurrence are different: Preliminary Findings

Early identification of PCa patients at risk for biochemical recurrence (BCR) post-therapy will potentially complement definitive therapy with either neo- or adjuvant therapy to improve prognosis. BCR post definitive therapy is often associated with disease progression that might cause a bulge in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghose, Soumya, Shiradkar, Rakesh, Rusu, Mirabela, Mitra, Jhimli, Thawani, Rajat, Feldman, Michael, Gupta, Amar C., Purysko, Andrei S., Ponsky, Lee, Madabhushi, Anant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696460/
https://www.ncbi.nlm.nih.gov/pubmed/29158516
http://dx.doi.org/10.1038/s41598-017-13443-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696460/
https://www.ncbi.nlm.nih.gov/pubmed/29158516
http://dx.doi.org/10.1038/s41598-017-13443-8

Ejemplares similares